TWiV 1008: Clinical update with Dr. Daniel Griffin
May 20, 2023•32 min•Ep. 1008
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In his weekly clinical update, Dr. Griffin discusses variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC, ventilation in buildings, COVID-19 mortality among selective serotonin reuptake inhibitor users, risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses, trajectories of the evolution of post COVID-19 condition, and efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Virus variant clinical performance of a SARS-CoV-2 rapid antigen test (CID)
- Ventilation in buildings (CDC)
- COVID-19 mortality among SSRI users (CMI)
- Risk of post-acute sequelae of SARS-CoV-2 infection associated with sleep apnea (SLEEP)
- Trajectories of the evolution of post COVID-19 condition (IJID)
- Efficacy of cognitive behavioral therapy targeting fatigue following COVID-19 (CAD)
- Contribute to our FIMRC fundraiser at PWB
- Letters read on TWiV 1008
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android